47 results
SC 14D9
PNT
POINT Biopharma Global Inc.
13 Oct 23
Tender offer solicitation
7:11am
June 5, 2023 through June 8, 2023, representatives of POINT met with representatives of Lilly while attending a healthcare conference, during which
SC TO-T
EX-99
PNT
POINT Biopharma Global Inc.
13 Oct 23
Third party tender offer statement
6:52am
of Lilly while attending a healthcare conference, during which representatives of Lilly indicated Lilly’s potential interest in the radiopharmaceuticals … served as chief counsel, corporate and securities at GE Healthcare from 2018 to 2019. Between 2015 and 2018, Mr. Anderson held various positions
ARS
2022 FY
PNT
POINT Biopharma Global Inc.
1 May 23
Annual report to shareholders
1:52pm
relationships with healthcare providers and physicians and third-party payors are subject to complex and extensive healthcare laws and regulations. ◦ Healthcare … , issuance by the FDA or other regulatory authorities of safety alerts, Dear Healthcare Provider letters, press releases or other communications
424B3
xpbbisj6b0byk3bh6m0
11 Jul 22
Prospectus supplement
4:32pm
POS AM
p8r6zk yzt0vfoyj
1 Jul 22
Prospectus update (post-effective amendment)
4:17pm
DEF 14A
cms eu5xdq
28 Apr 22
Definitive proxy
8:36am
424B3
rzb3m
31 Mar 22
Prospectus supplement
11:42am
POS AM
8wn60kncjazshm9 4e
25 Mar 22
Prospectus update (post-effective amendment)
8:41am
424B3
cdtbmo7f10 wfa
5 Aug 21
Prospectus supplement
4:26pm
8-K
gd66 imog6i
21 Jun 21
Other Events
4:04pm
425
dulsqb0k1nx
21 Jun 21
Business combination disclosure
4:02pm
424B3
58vvth1
9 Jun 21
Prospectus supplement
4:42pm
8-K
EX-99.1
8hsu03
9 Jun 21
Other Events
4:40pm
425
EX-99.1
jxhhq2uq8 xjs2
9 Jun 21
Business combination disclosure
4:38pm